| Financial Year |
March 31 2023 |
| Monetary Funds |
2,743,363,859.74 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
677,010,193.68 |
| Advances to Suppliers |
497,176,064.77 |
| Other Receivables |
663,372,657.88 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,644,087,288.20 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
208,684,076.55 |
| Total Current Assets |
6,817,437,216.67 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,528,547,123.78 |
| Investment Properties |
-- |
| Fixed Assetes |
1,809,768,662.21 |
| Under-construction Projects |
186,321,583.22 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
132,008,344.38 |
| R&D expenses |
-- |
| Goodwill |
17,727,438.68 |
| Long-Term Deferred and Prepaid Expenses |
64,893,814.62 |
| Deferred Income Tax Assets |
148,074,098.44 |
| Other Non-Current Assets |
59,930,460.83 |
| Sub-Total of Non-Current Assets |
4,169,894,663.14 |
| Total Assets |
10,987,331,879.81 |
| Short-Term Loans |
1,743,612,618.31 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,699,449,167.33 |
| Accounts Payable |
1,659,093,066.17 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
75,088,920.55 |
| Taxes Payable |
21,956,810.72 |
| Interest Payable |
4,405,031.25 |
| Dividend Payable |
-- |
| Other payables |
1,007,540,354.96 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
461,135,217.30 |
| Other Current Liabilities |
93,538,501.45 |
| Sub-Total of Current Liabilities |
7,480,941,591.00 |
| Long-term Loans |
59,024,856.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
809,019,096.73 |
| Special Payable |
-- |
| Estimatied Liabilities |
114,380,461.08 |
| Deferred Income Tax Liabilities |
1,500,469.21 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,223,495,873.66 |
| Total Liabilities |
8,704,437,464.66 |
| Paid-In Capital(Or Share Stock) |
5,850,316,427.00 |
| Capital Surplus |
4,397,037,113.39 |
| Surplus Reserve |
75,495,097.13 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-8,043,825,983.36 |
| Minority Stockholder's Interest |
-109,290.85 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,283,003,706.00 |
| Owner's Equity（Stockholder's Equity） |
2,282,894,415.15 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,987,331,879.81 |
